搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按相关度排序
按时间排序
搜狐
8 天
Svar Life Science-iLite CD3效应器,评估CD3介导的T细胞激活
双特异性T细胞结合剂Blinatumomab,针对B细胞上的CD19和T细胞上的CD3,并于2014年获得FDA批准用于治疗B细胞恶性肿瘤(1)。 Svar Life Science-iLite® CD3效应体测定细胞可以用于评估CD3介导的T细胞激活。 iLite CD3效应体测定细胞是经人工工程处理的细胞(Jurkat,ATCC #TIB-152)。
GitHub
8 天
3D modeling
Learn or level up your L337 game dev skills and build amazing games toge ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
今日热点
Reaches tentative union deal
2024 induction ceremony
Judge unseals new evidence
Philip Zimbardo dies at 91
G7 ministers back Ukraine
Netanyahu's home targeted
OK classroom Bible suit
Probes near miss in Austin
Nationwide blackout in Cuba
PG&E shuts off power
NK sending troops to RU?
NC breaks turnout record
School shooting report
Fire prompts evacuations
US deficit reaches $1.8T
La Nina could arrive soon
Republicans appeal ruling
Frozen waffles recalled
Ex-MN congressman dies
Bladder cancer drug pulled
Emergency abortion ruling
At decade-high level
To furlough 700 workers
Challenges military listing
$4M LAPD fentanyl seizure
Calif. oil refinery closure
Three Americans detained
Antitrust ruling delayed
反馈